{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:29:38Z","timestamp":1780752578774,"version":"3.54.1"},"reference-count":49,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Access Publication Fund of the University Hospital of Leipzig"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: Due to the high prevalence and incidence of cardio- and cerebrovascular diseases among dialysis-dependent patients with end-stage renal disease (ERSD) scheduled for kidney transplantation (KT), the use of antiplatelet therapy (APT) and\/or anticoagulant drugs in this patient population is common. However, these patients share a high risk of complications, either due to thromboembolic or bleeding events, which makes adequate peri- and post-transplant anticoagulation management challenging. Predictive clinical models, such as the HAS-BLED score developed for predicting major bleeding events in patients under anticoagulation therapy, could be helpful tools for the optimization of antithrombotic management and could reduce peri- and postoperative morbidity and mortality. Methods: Data from 204 patients undergoing kidney transplantation (KT) between 2011 and 2018 at the University Hospital Leipzig were retrospectively analyzed. Patients were stratified and categorized postoperatively into the prophylaxis group (group A)\u2014patients without pretransplant anticoagulation\/antiplatelet therapy and receiving postoperative heparin in prophylactic doses\u2014and into the (sub)therapeutic group (group B)\u2014patients with postoperative continued use of pretransplant antithrombotic medication used (sub)therapeutically. The primary outcome was the incidence of postoperative bleeding events, which was evaluated for a possible association with the use of antithrombotic therapy. Secondary analyses were conducted for the associations of other potential risk factors, specifically the HAS-BLED score, with allograft outcome. Univariate and multivariate logistic regression as well as a Cox proportional hazard model were used to identify risk factors for long-term allograft function, outcome and survival. The calibration and prognostic accuracy of the risk models were evaluated using the Hosmer\u2013Lemshow test (HLT) and the area under the receiver operating characteristic curve (AUC) model. Results: In total, 94 of 204 (47%) patients received (sub)therapeutic antithrombotic therapy after transplantation and 108 (53%) patients received prophylactic antithrombotic therapy. A total of 61 (29%) patients showed signs of postoperative bleeding. The incidence (p &lt; 0.01) and timepoint of bleeding (p &lt; 0.01) varied significantly between the different antithrombotic treatment groups. After applying multivariate analyses, pre-existing cardiovascular disease (CVD) (OR 2.89 (95% CI: 1.02\u20138.21); p = 0.04), procedure-specific complications (blood loss (OR 1.03 (95% CI: 1.0\u20131.05); p = 0.014), Clavien\u2013Dindo classification &gt; grade II (OR 1.03 (95% CI: 1.0\u20131.05); p = 0.018)), HAS-BLED score (OR 1.49 (95% CI: 1.08\u20132.07); p = 0.018), vit K antagonists (VKA) (OR 5.89 (95% CI: 1.10\u201331.28); p = 0.037), the combination of APT and therapeutic heparin (OR 5.44 (95% CI: 1.33\u201322.31); p = 0.018) as well as postoperative therapeutic heparin (OR 3.37 (95% CI: 1.37\u20138.26); p &lt; 0.01) were independently associated with an increased risk for bleeding. The intraoperative use of heparin, prior antiplatelet therapy and APT in combination with prophylactic heparin was not associated with increased bleeding risk. Higher recipient body mass index (BMI) (OR 0.32 per 10 kg\/m2 increase in BMI (95% CI: 0.12\u20130.91); p = 0.023) as well as living donor KT (OR 0.43 (95% CI: 0.18\u20130.94); p = 0.036) were associated with a decreased risk for bleeding. Regarding bleeding events and graft failure, the HAS-BLED risk model demonstrated good calibration (bleeding and graft failure: HLT: chi-square: 4.572, p = 0.802, versus chi-square: 6.52, p = 0.18, respectively) and moderate predictive performance (bleeding AUC: 0.72 (0.63\u20130.79); graft failure: AUC: 0.7 (0.6\u20130.78)). Conclusions: In our current study, we could demonstrate the HAS-BLED risk score as a helpful tool with acceptable predictive accuracy regarding bleeding events and graft failure following KT. The intensified monitoring and precise stratification\/assessment of bleeding risk factors may be helpful in identifying patients at higher risks of bleeding, improved individualized anticoagulation decisions and choices of antithrombotic therapy in order to optimize outcome after kidney transplantation.<\/jats:p>","DOI":"10.3390\/jcm11144025","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T20:52:41Z","timestamp":1657659161000},"page":"4025","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation"],"prefix":"10.3390","volume":"11","author":[{"given":"Hans","family":"Hau","sequence":"first","affiliation":[{"name":"Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, 04103 Leipzig, Germany"},{"name":"Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eckert","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Laudi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"V\u00f6lker","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0635-5112","authenticated-orcid":false,"given":"Sebastian","family":"Stehr","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rademacher","sequence":"additional","affiliation":[{"name":"Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seehofer","sequence":"additional","affiliation":[{"name":"Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sucher","sequence":"additional","affiliation":[{"name":"Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-8658","authenticated-orcid":false,"given":"Tobias","family":"Piegeler","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Jahn","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jebm.12235","article-title":"Antithrombotic medications in dialysis patients: A double-edged sword","volume":"10","author":"Vlachopanos","year":"2017","journal-title":"J. Evid. Based Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1525-139X.2003.16048.x","article-title":"Thrombosis in end-stage renal disease","volume":"16","author":"Casserly","year":"2003","journal-title":"Semin. Dial."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2215\/CJN.01810407","article-title":"Major bleeding in hemodialysis patients","volume":"3","author":"Holden","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/tri.12926","article-title":"Postoperative surgical-site hemorrhage after kidney transplantation: Incidence, risk factors, and outcomes","volume":"30","author":"Hachem","year":"2017","journal-title":"Transpl. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/tri.13387","article-title":"Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation\u2014A retrospective study","volume":"32","author":"Berg","year":"2019","journal-title":"Transpl. Int."},{"key":"ref_6","first-page":"114","article-title":"Evaluation of Heparin Anticoagulation Protocols in Post\u2013Renal Transplant Recipients (EHAP-PoRT Study)","volume":"69","author":"Ng","year":"2016","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.transproceed.2011.07.018","article-title":"Risk Factors for Early Hemorrhagic and Thrombotic Complications After Kidney Transplantation","volume":"43","author":"Pawlicki","year":"2011","journal-title":"Transplant. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1345\/aph.1D510","article-title":"Bleeding and Thrombosis in High-Risk Renal Transplantation Candidates Using Heparin","volume":"38","author":"Mathis","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0037-1598061","article-title":"Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding","volume":"43","author":"Parks","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A New Risk Scheme to Predict Warfarin-Associated Hemorrhage","volume":"58","author":"Fang","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-06-0390","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Nieto","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"g4606","DOI":"10.1136\/bmj.g4606","article-title":"Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: Cohort study to derive and validate the QBleed scores","volume":"349","author":"Coupland","year":"2014","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: A derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline Risk of Major Bleeding in Non\u2013ST-Segment\u2013Elevation Myocardial Infarction","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00380-019-01405-1","article-title":"Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome","volume":"34","author":"Castini","year":"2019","journal-title":"Heart Vessels"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am. J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00000658-199809000-00002","article-title":"Experience with 500 simultaneous pancreas-kidney transplants","volume":"228","author":"Sollinger","year":"1998","journal-title":"Ann. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/SLA.0b013e3181b76d2b","article-title":"One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up","volume":"250","author":"Sollinger","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_25","unstructured":"(2021, July 11). Eurotranplant Chapter 9: The Donor. Available online: https:\/\/www.eurotransplant.org\/wp-content\/uploads\/2020\/01\/H9-The-Donor-Februar-2020.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2004-832389","article-title":"Technik der Multiorganentnahme","volume":"39","author":"Ladurner","year":"2004","journal-title":"Viszeralchirurgie"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hau, H.-M., Jahn, N., Brunotte, M., Lederer, A.A., Sucher, E., Rasche, F.M., Seehofer, D., and Sucher, R. (2020). Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-0506-9"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sucher, R., Rademacher, S., Jahn, N., Brunotte, M., Wagner, T., Alvanos, A., Sucher, E., Seehofer, D., Scheuermann, U., and Hau, H.-M. (2019). Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1649-7"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Scheuermann, U., Rademacher, S., Wagner, T., Lederer, A., Hau, H.-M., Seehofer, D., and Sucher, R. (2021). Influence of Multiple Donor Renal Arteries on the Outcome and Graft Survival in Deceased Donor Kidney Transplantation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194395"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/gfz040","article-title":"Pros and cons of antithrombotic therapy in end-stage kidney disease: A 2019 update","volume":"34","author":"Burlacu","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.phrs.2017.12.004","article-title":"Bleeding in advanced CKD patients on antithrombotic medication\u2014A critical appraisal","volume":"129","author":"Burlacu","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjcard.2010.12.009","article-title":"In-Hospital Major Bleeding During ST-Elevation and Non\u2013ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry\u00ae-GWTGTM","volume":"107","author":"Mathews","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/ndt\/gfl338","article-title":"Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era","volume":"21","author":"Rufino","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.transproceed.2005.02.018","article-title":"Increased Risk of Hemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Posttransplantation","volume":"37","author":"Kusyk","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.transproceed.2009.02.077","article-title":"Vascular Complications in Renal Transplantation: A Single-Center Experience in 1367 Renal Transplantations and Review of the Literature","volume":"41","author":"Dimitroulis","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00007890-199804150-00013","article-title":"Early loss of renal transplants in patients with thrombophilia","volume":"65","author":"Fischereder","year":"1998","journal-title":"Transplantation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00007890-200109270-00016","article-title":"Hypercoagulable states in renal transplant candidates: Impact of anticoagulation upon incidence of renal allograft thrombosis","volume":"72","author":"Friedman","year":"2001","journal-title":"Transplantation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13741-020-00170-4","article-title":"Markedly increased risk of postoperative bleeding complications during perioperative bridging anticoagulation in general and visceral surgery","volume":"9","author":"Lock","year":"2020","journal-title":"Perioper. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40620-015-0185-1","article-title":"Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation","volume":"28","author":"Musetti","year":"2015","journal-title":"J. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1399-0012.2010.01293.x","article-title":"Perioperative anticoagulation and antiplatelet therapy in renal transplant: Is there an increase in bleeding complication?","volume":"25","author":"Eng","year":"2011","journal-title":"Clin. Transplant."},{"key":"ref_41","first-page":"e931648-1","article-title":"Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?","volume":"26","author":"Machado","year":"2021","journal-title":"Ann. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jamcollsurg.2008.08.032","article-title":"Effect of Body Mass Index on Short-Term Outcomes after Colectomy for Cancer","volume":"208","author":"Merkow","year":"2009","journal-title":"J. Am. Coll. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00268-015-3358-0","article-title":"Morbid Obesity is Associated with Increased Mortality, Surgical Complications, and Incremental Health Care Utilization in the Peri-Operative Period of Colorectal Cancer Surgery","volume":"40","author":"Hussan","year":"2016","journal-title":"World J. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e003831","DOI":"10.1161\/JAHA.116.003831","article-title":"Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery","volume":"6","author":"Ghanta","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/TA.0000000000000490","article-title":"Obesity and clotting","volume":"78","author":"Kornblith","year":"2015","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jtcvs.2012.08.047","article-title":"The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation","volume":"144","author":"Kilic","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/lt.22343","article-title":"Impact of center volume on outcomes of increased-risk liver transplants","volume":"17","author":"Ozhathil","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"205435811773552","DOI":"10.1177\/2054358117735523","article-title":"Center Variation and the Effect of Center and Provider Characteristics on Clinical Outcomes in Kidney Transplantation: A Systematic Review of the Evidence","volume":"4","author":"Tsampalieros","year":"2017","journal-title":"Can. J. Kidney Health Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2019.02.019","article-title":"Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes","volume":"74","author":"Sonnenberg","year":"2019","journal-title":"Am. J. Kidney Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/4025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:48:39Z","timestamp":1760140119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/4025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":49,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcm11144025"],"URL":"https:\/\/doi.org\/10.3390\/jcm11144025","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}